Correlation Between SPDR SP and First Trust

Can any of the company-specific risk be diversified away by investing in both SPDR SP and First Trust at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SPDR SP and First Trust into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SPDR SP Pharmaceuticals and First Trust NYSE, you can compare the effects of market volatilities on SPDR SP and First Trust and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SPDR SP with a short position of First Trust. Check out your portfolio center. Please also check ongoing floating volatility patterns of SPDR SP and First Trust.

Diversification Opportunities for SPDR SP and First Trust

0.52

Correlation Coefficient

SPDR SP  First Trust

Very weak diversification

The 3 months correlation between SPDR and First is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding SPDR SP Pharmaceuticals and First Trust NYSE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on First Trust NYSE and SPDR SP is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SPDR SP Pharmaceuticals are associated (or correlated) with First Trust. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of First Trust NYSE has no effect on the direction of SPDR SP i.e., SPDR SP and First Trust go up and down completely randomly.

Pair Corralation between SPDR SP and First Trust

Considering the 90-day investment horizon SPDR SP Pharmaceuticals is expected to under-perform the First Trust. But the etf apears to be less risky and, when comparing its historical volatility, SPDR SP Pharmaceuticals is 1.26 times less risky than First Trust. The etf trades about -0.28 of its potential returns per unit of risk. The First Trust NYSE is currently generating about -0.08 of returns per unit of risk over similar time horizon. If you would invest  17,005  in First Trust NYSE on September 24, 2024 and sell it today you would lose (357.40) from holding First Trust NYSE or give up 2.1% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

SPDR SP Pharmaceuticals  vs.  First Trust NYSE

SPDR SP Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SPDR SP Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, SPDR SP is not utilizing all of its potentials. The latest stock price confusion, may contribute to short-horizon losses for the traders.

First Trust NYSE

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days First Trust NYSE has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental drivers, First Trust is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with SPDR SP and First Trust

The main advantage of trading using opposite SPDR SP and First Trust positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SPDR SP position performs unexpectedly, First Trust can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in First Trust will offset losses from the drop in First Trust's long position.

The idea behind SPDR SP Pharmaceuticals and First Trust NYSE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.